Detalles de la búsqueda
1.
Mitapivat versus Placebo for Pyruvate Kinase Deficiency.
N Engl J Med
; 386(15): 1432-1442, 2022 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417638
2.
Clinically meaningful improvements in patient-reported outcomes in mitapivat-treated patients with pyruvate kinase deficiency.
Am J Hematol
; 99(7): 1415-1419, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38712615
3.
Epidemiology of clinically significant forms of alpha- and beta-thalassemia: A global map of evidence and gaps.
Am J Hematol
; 98(9): 1436-1451, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37357829
4.
Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom.
Br J Haematol
; 184(2): 202-214, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30239982
5.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Lancet
; 390(10094): 555-566, 2017 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28600132
6.
Brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma who are Ineligible for autologous stem cell transplant: A Germany and United Kingdom retrospective study.
Eur J Haematol
; 99(6): 553-558, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28949403
7.
Evaluating treatments and corresponding costs of prostate cancer patients treated within an inpatient or hospital-based outpatient setting.
Future Oncol
; 11(3): 439-47, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25675125
8.
Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency.
Hematology
; 29(1): 2290746, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38095306
9.
Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial.
J Patient Rep Outcomes
; 7(1): 112, 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943362
10.
Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial.
Lancet Haematol
; 9(10): e724-e732, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35988546
11.
The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review.
Expert Rev Hematol
; 13(4): 405-419, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31958235
12.
Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study.
Eur J Cancer
; 133: 120-130, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32502876
13.
Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma.
Clin Ther
; 41(3): 477-493.e7, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30773308
14.
Brentuximab vedotin consolidation post-autologous stem cell transplant in Hodgkin lymphoma patients at risk of residual disease: number needed to treat.
Leuk Lymphoma
; 59(1): 69-76, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28583027
15.
Real-world effectiveness of brentuximab vedotin versus physicians' choice chemotherapy in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplantation in the United Kingdom and Germany.
Leuk Lymphoma
; 59(6): 1413-1419, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29045163
16.
Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea.
Am Health Drug Benefits
; 10(3): 113-119, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28626508
17.
Comparing hospital-based resource utilization and costs for prostate cancer patients with and without bone metastases.
Appl Health Econ Health Policy
; 12(5): 547-57, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25005491
18.
Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers.
Am Health Drug Benefits
; 6(5): 264-74, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24991362
Resultados
1 -
18
de 18
1
Próxima >
>>